Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 3/20 | 0.53 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 4/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8519552 | 1.00 | LPL (0.53) | LPLLIPGPPARAPPARGTP53 | |
| SCHEMBL489093 | 1.00 | LPL (0.53) | LPLLIPGPPARAPPARGTP53 | |
| SCHEMBL5036861 | 0.98 | LPL (0.51) | LPLLIPGPPARAPPARGTP53 | |
| SCHEMBL489025 | 0.93 | TP53 (0.47) | LPLLIPGPPARAPPARGTP53 | |
| SCHEMBL30540423 | 0.93 | TP53 (0.47) | LPLLIPGPPARAPPARGTP53 | |
| SCHEMBL595251 | 0.91 | TP53 (0.47) | LPLLIPGTP53TDP1 | |
| SCHEMBL29253203 | 0.87 | LIPG (0.43) | LPLLIPGPPARAPPARGTHRA | |
| SCHEMBL488945 | 0.85 | TP53 (0.50) | LPLLIPGTP53TDP1THRB | |
| SCHEMBL30257186 | 0.85 | TP53 (0.50) | LPLLIPGTP53TDP1THRB | |
| SCHEMBL2921023 | 0.84 | LPL (0.54) | LPLLIPGPPARAPPARGTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117855600-A | Gel polymer electrolyte and application thereof | 广州天赐高新材料股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4316850-B1 | ELECTRON BEAM CURING INKJET INK, INK SET, AND IMAGE RECORDING METHOD | FUJIFILM CORP (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4286163-B1 | ELECTRON BEAM CURABLE INK, AND IMAGE RECORDING METHOD | FUJIFILM CORP (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-12545780-B2 | Flexible metal clad laminates and methods of preparation thereof | NOTARK CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| US-12501540-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| EP-4660262-A1 | ACTIVE ENERGY RAY-CURABLE INKJET INK, ACTIVE ENERGY RAY-CURABLE INK SET, AND IMAGE RECORDING METHOD | FUJIFILM Corporation (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-12492315-B2 | Article with recorded image, active energy ray curable-type ink, ink set, and manufacturing method of article with recorded image | FUJIFILM CORPORATION (JP) | 2025-12-09 | — | — | US | disclosed |
| US-20250367910-A1 | LAMINATES BASED ON COPOLYMERS OF DIISOALKENYLARENES | NOTARK CORPORATION (US) | 2025-12-04 | — | — | US | disclosed |
| US-12473449-B2 | Ink set, image recording method, image recorded article, and three-dimensional article and method for producing the same | FUJIFILM CORPORATION (JP) | 2025-11-18 | — | — | US | disclosed |
| US-5118867-A | Hydroformylation of an definically unsaturated compound, rhodium catalyst, a soluble ammonium salt of a sulfonated phosphorous acid triester | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-02 | — | — | US | disclosed |
| EP-0149894-B1 | HYDROFORMYLATION PROCESS | DAVY McKEE (LONDON) LIMITED (GB) | 1989-03-01 | — | — | EP | disclosed |
| EP-0096986-B1 | HYDROFORMYLATION PROCESS | DAVY McKEE (LONDON) LIMITED (GB) | 1987-04-22 | — | — | EP | disclosed |
| US-4567306-A | TERITARY AMINE STABILIZER FOR PHOSPHITE LIGAND OF RHODIUM CATALYST | DAVY MCKEE (LONDON) LIMITED (GB) | 1986-01-28 | — | — | US | disclosed |
| EP-0096987-B1 | HYDROFORMYLATION PROCESS | DAVY McKEE (LONDON) LIMITED (GB) | 1985-11-13 | — | — | EP | disclosed |
| EP-0149894-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1985-07-31 | — | — | EP | disclosed |
| US-4496768-A | USING RHODIUM COMPLEX CATALYST WITH CARBON MONOXIDE AND CYCLIC PHOSPHITE | DAVY MCKEE LIMITED (GB) | 1985-01-29 | — | — | US | disclosed |
| US-4496769-A | USING RHODIUM-CARBON MONOXIDE- PHOSPHITE COMPLEX CATALYST | DAVY MCKEE (LONDON) LIMITED (GB) | 1985-01-29 | — | — | US | disclosed |
| EP-0096986-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |
| EP-0096987-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | PSMA1, PSMB10, RAD51 | LPL 1735/4885LIPG 4055/4885PPARA 1280/4885 |
| US-12545780-B2 | Flexible metal clad laminates and methods of preparation thereof | DSG1, CDH1, CAD | LPL 2070/4885LIPG 1612/4885PPARA 3413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.